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Autoradiography of excitatory and inhibitory amino acid binding sites in human dentate nuclei indicated virtually no binding to N-methyl- 
D-aspartate (NMDA) or ~,-aminobutyric acidB (GABAB) binding sites, and a low density of kainate binding sites, a-Amino-3-hydroxy-5- 
methylisoxazole-4-propionic acid, metabotropie-quisqualate, benzodiazepine, and 7-aminobutyric acid A (GABAA) binding sites were present 
in moderate abundance. Our NMDA results differ from those found previously in rodents. GABA A receptors are probably the primary 
mediators of inhibitory neurotransmission and a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid and metabotropic-quisqualate receptors 
are probably the primary mediators of excitatory neurotransmission within the human deep cerebellar nuclei. 
The deep cerebellar nuclei (DCN) give rise to virtu- 
ally the only projection conveying information out of the 
cerebellum. The inhibitory amino acid ~-aminobutyric 
acid (GABA) and the excitatory amino acids (EAAs) 
are important neurotransmitters within the DCN. The 
DCN receive GABAergic afferents from the Purkinje 
cells of the cerebellar cortex and EAAergic input from 
collaterals of mossy and climbing fibers innervating the 
cerebellar c o r t e x  4"7'10'12'21'23'24'27. In addition, the DCN 
contain local interneurons that are thought to be 
GABAergic 7'19. DCN neurons projecting out of the cer- 
ebellum are thought to be EAAergic TM and have recur- 
rent collaterals within the DCN 7. 
An important aspect of both GABA- and EAA-me- 
diated neurotransmission is the existence of receptor 
subtypes with distinctive physiological properties. Two 
types of GABA receptors are recognized. The GABA A 
receptor is an ionotropic receptor coupled to an inhibi- 
tory chloride channel and modulated by an integral ben- 
zodiazepine (BDZ) binding site 9. The GABA B receptor 
is a G-protein-coupled receptor that modulates potas- 
sium and calcium channels 5. Four types of well defined 
EAA receptors are presently recognized 15. The N-me- 
thyl-D-aspartate (NMDA) receptor is an ionotropic re- 
ceptor that produces long latency, long duration depo- 
larizations and is linked to an ionophore that permits 
calcium influx. The NMDA receptor complex is also dis- 
tinguished by the presence of additional binding sites for 
glycine (Gly), the dissociative anesthetics, and poly- 
amines. The a-amino-3-hydroxy-5-methylisoxazole-4- 
propionic acid (AMPA) receptor (known also as the ion- 
otropic-quisqualate receptor) and the kainate (KA) re- 
ceptor mediate conventional fast neurotransmission. The 
metabotropic-quisqualate (MET) receptor is linked to 
the inositol phospholipid second messenger system. To 
explore the role of GABA and EAAs within the human 
DCN, we used receptor autoradiography to determine 
which GABA and EAA binding site subtypes were 
present within the dentate nucleus (DN) of man. 
Six brains were obtained at necropsy from individuals 
without neurologic disease. The average age was 56 years 
(range 31-69) and the average post-mortem delay was 
13 h (range 10-16). Brains were bisected in the sagittal 
plane; one hemisphere sectioned coronally into 1 cm 
slabs; the slabs frozen in crushed dry ice and stored at 
-70 °C. Blocks containing the dentate nucleus (DN) and 
cerebellar cortex were cut out of the slabs and 20 mi- 
cron sections were cut with a Lipshaw cryostat. Sections 
were thaw mounted onto gelatin coated slides and stored 
at -20 °C for 1 to 2 days. 
EAA and GABA binding site subtypes were assayed 
with standard techniques (Table 1) 1"6'8'13'20"22'25'28 . A l l  
assays were run in triplicate or duplicate. GABAA, 
GABAB, NMDA, AMPA, MET, KA, and GLY bind- 
ing sites were all assayed in a similar manner. Sections 
were prewashed in bufer  at 4 °C, dried under a stream 
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TABLE I 
GABA and EAA binding site assays 
Binding site Ligand Specific activity Conc. Buffer Blockers Blank 
BDZ [3H]Flunitrazepam 85 Ci/mmol 5 nM 50 mM Tris-acetate 5/~M Clonazepam 
pH 7.4, 4 °C 
GABA A [3H]GABA 52 Ci/mmol 20 nM 50 mM Tris-Cl + 100/~M Baclofen 100 #M 
2.5 mM CaC12 Isoguvacine 
pH 7.2, 4 °C 
GABA n [3H]GABA 52 Ci/mmol 20 nM 50 mM Tris-Cl + 10/zM 100 #M 
2.5 mM CaCI 2 Isoguvacine Baclofen 
pH 7.4, 4 °C 
NMDA [3H]Glutamate 56 Ci/mmol 65 nM 50 mM Tris-acetate 2.5/~M Quisqualate + 1 mM NMDA or 
pH 7.4, 4 °C 1/~M Kainate 100 #M CPP 
Glycine [3H]Glycine 18.7 Ci/mmol 100 nM 50 mM Tris-aeetate 1 #M Strychnine 1 mM Glycine 
pH 7.4, 4 °C 
MK-801 [3H]MK-801 22.5 Ci/mmol 10 nM 50 mM Tris-acetate 10 #M MK-801 
pH 7.4, 25 °C + 
30 #M Glycine + 
100 #M Glutamate 
AMPA [3H]AMPA 29.2 Ci/mmol 35 nM 50 mM Tris-CI + 1 #M Glutamate 
2.5 mM CaCI2 + 
30 mM KSCN 
pH 7.2, 4 °C 
MET [3H]Glutamate 56 Ci/mmol 100 nM 50 mM Tris-Cl + 100/~M NMDA + 2.5/~M 
2.5 mM CaC12 + 10 #M AMPA Quisqualate 
30 mM KSCN 
pH 7.2, 4 °C 
Kainate [3H]Kainate 5.9 Ci/mmol 60 nM 50 mM Tris-acetate 100 #M Kainate 
pH 7.2, 4 °C 
of cool air and immersed in cytomailers containing buffer 
(4 °C) with radioactive ligand and selective blocking 
agents. Af te r  an appropriate incubation period,  the sec- 
TABLE II 
The density of excitatory and inhibitory binding sites in the den- 
tate nucleus 
All values in pmol/mg protein (S.E.M.). Percent of cerebeilar 
cortex is the ratio of DN to cerebellar cortex binding, an index 
of the relative level of each binding site. N.S., no significant 
binding. 
Binding site Binding site levels % cerebellar cortex 
Benzodiazepine 0.076 (0.015) 23% 
GABA A 0.046 (0.013) 5% 





AMPA 0.271 (0.012) 35% 
Kainate 0.063 (0.004) 10% 
Metabotropic 0.088 (0.010) 22% 
/ 
Fig. 1. Autoradiographs of the GABA and EAA binding sites in 
the dentate nucleus. (A) Benzodiazepine binding; (B) GABA A 
binding; (C) GABA B binding; (D) AMPA binding; (E) strychnine- 
insensitive [3H]glycine binding, a measure of N-methyl-D-aspartate 
binding sites; (F) kainate binding; (G) metabotropic binding. Bar 
= 2 m m .  
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tions received 3 (GABA assays) or 4 (remaining assays) 
quick squirts of buffer (4 °C) followed by one (GABA 
assays) or two (remaining assays) quick squirts of 2.5% 
glutaraldehyde in acetone, and dried under a stream of 
hot air. 
MK-801 binding was assessed with the method of 
Sakurai et al. (Table I) 2z. Sections were prewashed in 
buffer for 30 min at 4 °C, dried under a stream of cool 
air, and immersed in ligand solution containing 20 nM 
[3H]MK-801 for 120 min at room temperature. Follow- 
ing incubation, sections were rinsed in buffer at 4 °C for 
80 rain, and dried under a stream of hot air. 
To measure BDZ binding, sections received 3 × 10 
min washes in buffer (4 °C), dried under a stream of cool 
air, and immersed in ligand solution for 30 min. Follow- 
ing incubation with ligand, sections received one quick 
dip in buffer (4 °C) followed by 2 × 5 min rinses in 
buffer (4 °C), and were dried under a stream of hot air. 
Slides were then apposed to tritium sensitive film (Hy- 
perfilm, Amersham) and exposed along with known ra- 
dioactive standards for ten days to six weeks. Films were 
developed in Kodak D-19 and binding site density was 
quantitated with computer assisted densitometry using 
the MCID system (Imaging Research, St. Catherines, 
Ont.). To give a relative index of the level of binding 
within the DN, ligand binding in cerebellar cortex was 
also measured and the ratio of DN to cerebellar cortical 
binding was computed. Cerebellar cortex was present on 
all blocks of tissue used in this study and contains high 
levels of all GABA and EAA binding sites, allowing use 
of cerebellar cortical values for comparison with the DN. 
Data analysis showed that only some receptor sub- 
types were present within the DN (Table II, Fig. 1). 
NMDA binding sites, whether assayed with [3H]gluta- 
mate, [3H]MK-801, or [3H]glycine, were not found within 
the DN (Fig. 1, Table II). Similarly, GABA a binding 
sites were not found within the DN. The level of KA 
binding within the DN was low, less than 10% of cere- 
beUar cortical binding. AMPA, MET, BDZ, and 
GABA A binding sites were readily identified within the 
DN (Table II, Fig. 1). AMPA, MET, and BDZ binding 
was at least 20% of cerebellar cortical binding levels. 
GABA A binding was 5% of cerebellar cortical binding, 
however, this apparently low level of relative binding 
reflects the very high livel of GABA A binding in cere- 
bellar cortex (see Albin and Gilman J). BDZ binding 
may give a better measure of the relative level of 
GABAA/BDZ binding sites in the DN. 
Our data suggest that GABAA/BDZ receptors are the 
primary mediators of inhibitory neurotransmission and 
that AMPA and MET receptors are the primary medi- 
ators of excitatory neurotransmission within the human 
DN. Given the similarities in connectional anatomy and 
cytoarchitecture among the DCN, our findings may ap- 
ply also to the other nuclei of the DCN. Our GABA 
binding site results are similar to those documented in 
prior autoradiographic studies of rodent and human cere- 
bellum 3"z6. In addition, Meinecke et al. have shown that 
DCN neuron perikarya and dendrites contain BDZ re- 
ceptor immunoreactivity ~4. EAA binding sites in the 
DCN have not been studied carefully in rodents or other 
species. Few prior autoradiographic studies comment on 
EAA binding sites within the DCN. Monaghan et al. 
found a low, but measureable density of NMDA bind- 
ing sites within the rat DCN 17, and Monaghan and Cot- 
man found a low density of KA binding sites within the 
lateral deep cerebellar nucleus of the rat ~6, the homo- 
logue of the primate DN. Rat DCN neurons respond to 
iontophoretically applied glutamate, aspartate, NMDA, 
and quisqualate e'll, and responses to glutamate are par- 
tially blocked by specific antagonists of either NMDA 
and non-NMDA receptors 2. These data indicate the 
presence of both NMDA and ionotropic-quisqualate (i.e. 
AMPA) receptors on DCN neurons. Our finding that 
the human DN appears to lack NMDA binding sites, 
while these binding sites/receptors are present in the 
DCN of rats, suggests a significant interspecies differ- 
ence in the organization of EAAergic pathways within 
the DCN. 
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